ArticleSensors (Basel, Switzerland)2021
Expert Hypertension Detection System Featuring Pulse Plethysmograph Signals and Hybrid Feature Selection and Reduction Scheme.
Article in Sensors (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 43 citations in OpenAlex.
- The Potential Mechanisms of Catechins in Tea for Anti-Hypertension: An Integration of Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.Foods (Basel, Switzerland) · 2024Article
- Experimental Exploration of Multilevel Human Pain Assessment Using Blood Volume Pulse (BVP) Signals.Sensors (Basel, Switzerland) · 2023Article
- Intelligent Wearable Wrist Pulse Detection System Based on Piezoelectric Sensor Array.Sensors (Basel, Switzerland) · 2023Article
- A Robust Design-Based Expert System for Feature Selection and COVID-19 Pandemic Prediction in Japan.Healthcare (Basel, Switzerland) · 2022Article
- Factors affecting treatment adherence among patients with hypertension based on the PRECEDE model: A cross-sectional study from a delay discounting perspective.International journal of clinical and health psychology : IJCHPArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension is an antecedent to cardiac disorders. According to the World Health Organization (WHO), the number of people affected with hypertension will reach around 1.56 billion by 2025. Early detection of hypertension is imperative to prevent the complications caused by cardiac abnormalities. Hypertension usually possesses no apparent detectable symptoms; hence, the control rate is significantly low. Computer-aided diagnosis based on machine learning and signal analysis has recently been applied to identify biomarkers for the accurate prediction of hypertension. This research proposes a new expert hypertension detection system (EHDS) from pulse plethysmograph (PuPG) signals for the categorization of normal and hypertension. The PuPG signal data set, including rich information of cardiac activity, was acquired from healthy and hypertensive subjects. The raw PuPG signals were preprocessed through empirical mode decomposition (EMD) by decomposing a signal into its constituent components. A combination of multi-domain features was extracted from the preprocessed PuPG signal. The features exhibiting high discriminative characteristics were selected and reduced through a proposed hybrid feature selection and reduction (HFSR) scheme. Selected features were subjected to various classification methods in a comparative fashion in which the best performance of 99.4% accuracy, 99.6% sensitivity, and 99.2% specificity was achieved through weighted
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.